122 related articles for article (PubMed ID: 9222474)
1. High-dose medroxyprogesterone acetate for the treatment of dysfunctional uterine bleeding in 24 adolescents.
Aksu F; Madazli R; Budak E; Cepni I; Benian A
Aust N Z J Obstet Gynaecol; 1997 May; 37(2):228-31. PubMed ID: 9222474
[TBL] [Abstract][Full Text] [Related]
2. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
[TBL] [Abstract][Full Text] [Related]
3. 21-year-old woman with menstrual irregularity, 1 year later.
Daley J; Delbanco TL; Hartman EE
JAMA; 1997 Nov; 278(20):1699. PubMed ID: 9388091
[No Abstract] [Full Text] [Related]
4. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
[TBL] [Abstract][Full Text] [Related]
5. Catamenial mononeuropathy and radiculopathy.
Cirak B; Guven MB
J Neurosurg; 1999 Feb; 90(2):374. PubMed ID: 9950514
[No Abstract] [Full Text] [Related]
6. Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study Group.
Nand SL; Webster MA; Baber R; O'Connor V
Obstet Gynecol; 1998 May; 91(5 Pt 1):678-84. PubMed ID: 9572210
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with withdrawal bleeding after administration of oral dydrogesterone or medroxyprogesterone acetate in women with secondary amenorrhea.
Battino S; Ben-Ami M; Geslevich Y; Weiner E; Shalev E
Gynecol Obstet Invest; 1996; 42(2):113-6. PubMed ID: 8878716
[TBL] [Abstract][Full Text] [Related]
8. Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial.
Munro MG; Mainor N; Basu R; Brisinger M; Barreda L
Obstet Gynecol; 2006 Oct; 108(4):924-9. PubMed ID: 17012455
[TBL] [Abstract][Full Text] [Related]
9. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and "add-back" therapy.
Murray SC; Muse KN
Fertil Steril; 1997 Feb; 67(2):390-3. PubMed ID: 9022620
[TBL] [Abstract][Full Text] [Related]
10. Membranous dysmenorrhea: the forgotten entity.
Rabinerson D; Kaplan B; Fisch B; Braslavski D; Neri A
Obstet Gynecol; 1995 May; 85(5 Pt 2):891-2. PubMed ID: 7724151
[TBL] [Abstract][Full Text] [Related]
11. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
Bhathena RK; Anklesaria BS; Ganatra AM; Pinto R
Br J Clin Pharmacol; 1998 Feb; 45(2):170-2. PubMed ID: 9491833
[TBL] [Abstract][Full Text] [Related]
12. A new progestogen-only medical therapy for outpatient management of acute, abnormal uterine bleeding: a pilot study.
Ammerman SR; Nelson AL
Am J Obstet Gynecol; 2013 Jun; 208(6):499.e1-5. PubMed ID: 23395929
[TBL] [Abstract][Full Text] [Related]
13. Medroxyprogesterone acetate treatment of abnormal uterine bleeding: factors predicting satisfaction.
Richter HE; Learman LA; Lin F; Varner RE; Hendrix SL; Summitt RL; Washington AE
Am J Obstet Gynecol; 2003 Jul; 189(1):37-42. PubMed ID: 12861135
[TBL] [Abstract][Full Text] [Related]
14. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
Lei ZW; Wu SC; Garceau RJ; Jiang S; Yang QZ; Wang WL; Vander Meulen TC
Contraception; 1996 Jun; 53(6):357-61. PubMed ID: 8773423
[TBL] [Abstract][Full Text] [Related]
15. [Dydrogesterone in the regulation of cycle disturbances in adolescence].
Chomczyk I; Sipowicz M; Sipowicz I
Ginekol Pol; 1999 May; 70(5):343-7. PubMed ID: 10462978
[TBL] [Abstract][Full Text] [Related]
16. Depot medroxy progesterone acetate: a poor preparatory agent for endometrial resection.
Kriplani A; Manchanda R; Monga D; Takkar D
Gynecol Obstet Invest; 2001; 52(3):180-3. PubMed ID: 11598360
[TBL] [Abstract][Full Text] [Related]
17. Treatment of endometriosis with depot medroxyprogesterone acetate: a preliminary experience.
Arowojolu AO
Afr J Med Med Sci; 2000 Mar; 29(1):55-8. PubMed ID: 11379470
[TBL] [Abstract][Full Text] [Related]
18. Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis.
Vercellini P; De Giorgi O; Oldani S; Cortesi I; Panazza S; Crosignani PG
Am J Obstet Gynecol; 1996 Aug; 175(2):396-401. PubMed ID: 8765259
[TBL] [Abstract][Full Text] [Related]
19. A 21-year-old woman with menstrual irregularity.
Davis A
JAMA; 1997 Apr 23-30; 277(16):1308-14. PubMed ID: 9109470
[No Abstract] [Full Text] [Related]
20. Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin interventions trial.
Lindenfeld EA; Langer RD
Obstet Gynecol; 2002 Nov; 100(5 Pt 1):853-63. PubMed ID: 12423841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
